Biology, Treatment and Genetic Epidemiology of Pediatric ALL - Alanazi, Nawaf;Awan Khalid, Tashfeen;Iqbal, Zafar
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
15 °P sammeln
  • Broschiertes Buch

Acute Lymphoblastic Leukemia is the most common childhood malignancy with over 80% cure rates in most parts of the world. Nevertheless, genetic abnormalities that are the major prognostic and determinants of treatment decision-making are not uniformly distributed in different geographic regions of the word, specifically fusion oncogenes. This is due to ethnic differences, racial and environmental variations, population mixing and delayed exposure to infection and drastic difference of socio-economic status. Because of huge clinical implications of genetics in pediatric ALL, it is one of the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Acute Lymphoblastic Leukemia is the most common childhood malignancy with over 80% cure rates in most parts of the world. Nevertheless, genetic abnormalities that are the major prognostic and determinants of treatment decision-making are not uniformly distributed in different geographic regions of the word, specifically fusion oncogenes. This is due to ethnic differences, racial and environmental variations, population mixing and delayed exposure to infection and drastic difference of socio-economic status. Because of huge clinical implications of genetics in pediatric ALL, it is one of the major contributing factors of disparities in ALL cure rates between developed world and developing countries. Therefore, cost-effective genetic testing should be part of routine clinical decision making in underdeveloped countries. Moreover, state-of-the-art genomic technologies should be employed to further explore variations in genetic epidemiology of ALL and its impact on differential diagnosis, prognostic stratification and therapeutic decision-making.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr Nawaf Alanazi completed fellowship of Royal College of Physicians Canada from Hospital of Sick Children University of Toronto in 2013. He's currently working as Dean College of Applied Medical Sciences and consultant hematologist/oncologist at King Abdulaziz National Guards Hospital Al-Ahsa. He has authored several books and research articles.